Nektar Therapeutics (NKTR) Amortizatization of Intangibles (2024 - 2026)

Nektar Therapeutics' Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at -$1.7 million for Q1 2026.

• In Q1 2026, Amortizatization of Intangibles fell 25.6% year-over-year to -$1.7 million; the TTM figure through Mar 2026 stood at -$5.9 million (up 22.02% YoY), while the FY2025 annual figure was -$5.5 million, up 40.36% from the prior year.
• Amortizatization of Intangibles for Q1 2026 stood at -$1.7 million, up from -$1.9 million in the prior quarter.
• The five-year high for Amortizatization of Intangibles was -$869000.0 in Q2 2025, with the low at -$3.1 million in Q1 2024.
• The 3-year median for Amortizatization of Intangibles is -$1.7 million (2026), against an average of -$1.8 million.
• The sharpest annual moves came in 2025 and 2026: Amortizatization of Intangibles surged 66.37% in 2025, then retreated 25.6% in 2026.
• Nektar Therapeutics' Amortizatization of Intangibles stood at -$1.5 million in 2024, then retreated by 23.08% to -$1.9 million in 2025, then grew by 11.92% to -$1.7 million in 2026.
• Business Quant data shows NKTR's Amortizatization of Intangibles at -$1.7 million in Q1 2026, -$1.9 million in Q4 2025, and -$1.4 million in Q3 2025.